...
首页> 外文期刊>International Journal of Legal Medicine >Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots
【24h】

Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots

机译:佐匹克隆的储存过程中佐加酮和纯正全血以及匹配的干血斑的降解

获取原文
获取原文并翻译 | 示例
           

摘要

Z-drugs such as zopiclone are increasingly involved in forensic cases. Its degradation occurs in solvents and biological fluids. It is assumed that hydrolysis largely accounts for the breakdown of zopiclone in aqueous media. Therefore, a stability study in blood at different storage conditions (−20, 4, 20, and 40°C) was performed to establish changes of the drug’s concentration with time, also including its degradation product 2-amino-5-chloropyridine (ACP). As removal of the aqueous phase may stabilize molecules that are prone to hydrolysis, it was assessed whether the use of dried blood spots (DBS) may be an alternative for storing and analyzing zopiclone and ACP. Spiked and authentic blood samples and corresponding DBS were analyzed using fully validated LC-MS/MS assays. There was agreement between the measurement of zopiclone from either blood or matching DBS in freshly prepared samples. Results showed that zopiclone was unstable in blood at all storage temperatures except at −20°C. Stability of zopiclone in spiked and authentic blood was increased in DBS compared to matching blood samples stored at the same condition. About 85 % of the initial concentration of zopiclone was still intact in DBS on day 8 at 20°C. ACP was formed from zopiclone in equimolar amounts in both media. Therefore, determination of both zopiclone and ACP may be helpful to estimate the initial concentration in both media. Pre-analytical conditions have a major impact on the recovery of zopiclone from blood. With respect to its known advantages, DBS can be recommended as a valuable alternative for the determination of zopiclone from blood.
机译:Z型药物(如佐匹克隆)越来越多地参与法医案件。其降解发生在溶剂和生物液体中。假定水解在很大程度上解释了佐匹克隆在水性介质中的分解。因此,进行了在不同储存条件下(-20、4、20和40°C的血液中)的稳定性研究,以确定药物浓度随时间的变化,还包括其降解产物2-氨基-5-氯吡啶(ACP) )。由于去除水相可以稳定易于水解的分子,因此评估了使用干血斑(DBS)是否可以替代存储和分析佐匹克隆和ACP。使用经过充分验证的LC-MS / MS分析法分析掺入的真实血液样本和相应的DBS。在新鲜制备的样品中,从血液或匹配的DBS中测定佐匹克隆的含量之间存在一致性。结果表明,除-20°C以外,佐匹克隆在所有储存温度下的血液中均不稳定。与在相同条件下存储的匹配血液样本相比,DBS中加标和真实血液中佐匹克隆的稳定性有所提高。在20°C的第8天,DBS中约18%的佐匹克隆初始浓度仍然完好无损。在两种培养基中,佐匹克隆以等摩尔量形成ACP。因此,同时测定佐匹克隆和ACP可能有助于估计两种培养基中的初始浓度。分析前的条件对从血液中回收佐匹克隆具有重大影响。关于其已知的优点,可以推荐DBS作为从血液中测定佐匹克隆的有价值的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号